Determine the necessary mass, volume, or concentration for preparing a solution.
≥97% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
| hba_count | 6 |
|---|---|
| Rotatable Bond | 10 |
| Canonical Smiles | CC1(C2=CC=CC=C2[N+](=C1C=CC=C3C(C4=CC=CC=C4N3CCCCCC(=O)ON5C(=O)CCC5=O)(C)C)C)C.[Cl-] |
|---|---|
| IUPAC Name | (2,5-dioxopyrrolidin-1-yl) 6-[(2E)-3,3-dimethyl-2-[(E)-3-(1,3,3-trimethylindol-1-ium-2-yl)prop-2-enylidene]indol-1-yl]hexanoate;chloride |
| InChIKey | KWDMHANYPGHTLW-UHFFFAOYSA-M |
| INCHI | 1S/C34H40N3O4.ClH/c1-33(2)24-14-8-10-16-26(24)35(5)28(33)18-13-19-29-34(3,4)25-15-9-11-17-27(25)36(29)23-12-6-7-20-32(40)41-37-30(38)21-22-31(37)39;/h8-11,13-19H,6-7,12,20-23H2,1-5H3;1H/q+1;/p-1 |
| Alternate CAS | 1032815-92-1 |
| Molecular Weight | 590.15 |
| Reaxy-Rn | 18831736 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=18831736&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 17, 2025 | C171425 | |
| Certificate of Analysis | Sep 17, 2025 | C171425 | |
| Certificate of Analysis | Sep 17, 2025 | C171425 | |
| Certificate of Analysis | Sep 17, 2025 | C171425 | |
| Certificate of Analysis | Sep 17, 2025 | C171425 | |
| Certificate of Analysis | Aug 12, 2025 | C171425 | |
| Certificate of Analysis | Sep 06, 2024 | C171425 | |
| Certificate of Analysis | Sep 06, 2024 | C171425 | |
| Certificate of Analysis | Dec 08, 2022 | C171425 | |
| Certificate of Analysis | Dec 08, 2022 | C171425 | |
| Certificate of Analysis | May 30, 2022 | C171425 | |
| Certificate of Analysis | Feb 25, 2022 | C171425 | |
| Certificate of Analysis | Jan 25, 2022 | C171425 |
| 1. Hanfei Xie, Lu Sun, Shili Yao, Xuefei Tian, Liming Jin, Yujie Dai, Yuanzheng Li, Yuxuan Li, Jianmin Fang, Peng Guo, Yingli Zhang. (2025) Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugates. GYNECOLOGIC ONCOLOGY, [PMID:40147093] [10.1016/j.ygyno.2025.03.027] |